ERBB2 and cancer: On the contrary, research by Sadanandam et al on HER-2 positive breast cancers and adjacent normal tissues concluded that cellular contamination from the primary tumor, and not field cancerization, is the likely cause of cancer adjacent normal tissue’s contribution in local disease recurrence [54].